
DIH Healthcare Integration Model
war-on-disease, 1-percent-treaty, medical-research, public-health, peace-dividend, decentralized-trials, dfda, dih, victory-bonds, health-economics, cost-benefit-analysis, clinical-trials, drug-development, regulatory-reform, military-spending, peace-economics, decentralized-governance, wishocracy, blockchain-governance, impact-investing
5. Why This Works Better Than Direct Payments
Avoids Perverse Incentives
- No “professional patients” gaming the system
- No coercion of desperate people
- Maintains doctor-patient relationship
- Preserves medical ethics
Reduces Friction
- Works within existing workflows
- Uses familiar insurance model
- No new systems to learn
- Doctors remain gatekeepers
Ensures Quality
- Medical oversight maintained
- Safety monitoring preserved
- Professional standards upheld
- Data quality assured
Real-World Example
Sarah has Type 2 Diabetes
Old System
- Metformin not working well
- No other options covered
- Pays $500/month for branded drug
- Still has poor control
With a decentralized institutes of health integration
- Doctor checks the portal for the trial network during visit
- Sees 5 relevant trials for new diabetes drugs
- Recommends Trial #3 based on Sarah’s profile
- Sarah enrolls with one click
- The trial coverage plan covers all costs
- Sarah pays $30 copay
- Gets experimental drug that might work better
- Reports blood sugar via app
- Data helps next patient
Implementation Requirements
Technical Infrastructure
- EMR integration APIs
- Pharmacy network connections
- Claims processing system
- Patient portal/app
- Data collection platform
Regulatory Framework
- Modified clinical trial regulations
- Insurance coordination rules
- Privacy/HIPAA compliance
- Prescription handling protocols
- Safety monitoring standards
Who Gets What
- Doctors: CME credits for trial participation
- Pharmacies: Dispensing fees for trial meds
- Hospitals: Infrastructure payments
- Insurers: Reduced long-term costs from better treatments
The Pre-1962 Model (The Model You’re Reinstating)
Before the 1962 Kefauver-Harris Amendment:
- Doctors could prescribe experimental treatments
- Patients and doctors decided together
- Innovation happened at bedside
- FDA only regulated safety, not efficacy
You bring this model back, but with
- Modern safety monitoring
- Real-time data collection
- Systematic outcome tracking
- Global knowledge sharing
- Insurance coverage for trials
Cost Structure (Realistic Numbers)
Per Patient Per Trial
- Medication costs: $200-2000/month (covered by the trial coverage pool)
- Monitoring costs: $100-500/month (covered by the trial coverage pool)
- Travel/time: $50-200/month (covered by the trial coverage pool)
- Patient copay: $20-50/month
- Data collection: $10/month (automated)
Total trial fund cost per patient: $360-2,710/month Traditional trial cost per patient: $6,800-13,600/month
Efficiency gain: 75-80% cost reduction
Why Doctors Will Love This
- More treatment options for desperate patients
- Professional satisfaction from contributing to pragmatic clinical trials
- CME credits for participation
- No liability (covered by trial insurance)
- Simple integration (one click in EMR)
- Better outcomes from expanded options
Why Patients Will Use This
- Affordable access to experimental treatments ($20-50 copay)
- Doctor recommended (trusted source)
- Insurance-like coverage (familiar model)
- No financial risk (the trial fund covers everything)
- Helping others while helping themselves
The Transition Plan
Phase 1: Pilot Programs (Year 1)
- 10 health systems
- 5 disease areas
- 10,000 patients
- Prove the model works
Phase 2: Regional Rollout (Year 2)
- 100 health systems
- 20 disease areas
- 100,000 patients
- Refine operations
Phase 3: National Scale (Year 3+)
- All willing providers
- All diseases
- Millions of patients
- Full integration
Integration Strategy
Your decentralized institutes of health (DIH) network isn’t trying to replace the healthcare system. It’s adding an “experimental treatment insurance layer” that:
- Works within existing infrastructure
- Respects current relationships
- Maintains safety standards
- Reduces costs dramatically
- Accelerates medical progress
It’s not revolution. It’s evolution. And it starts with a simple insurance card that says: “This covers your clinical trial participation.”